In September 2025, the NHC released a total of 59 cases of acceptance and approval information for "three new" foods, and the overall number of accepted and approved cases remained the same as that of last month. There were 11 novel food ingredients, among which 4 cases were accepted, 7 cases were postponed; There were 30 new varieties of food additives, among which 5 cases were accepted, 4 cases with review opinions issued, 14 cases were postponed, 7 cases were solicited opinions; There were 18 new varieties of food related products, among which 10 cases were accepted, 3 cases were denial of administration license, 5 cases were solicited opinions.

All novel food ingredients newly accepted this month are in a state of extension. L-ergothioneine remains a hot spot for application of novel food ingredients this month, with a total of 2 cases submitted and 3 cases postponed for correction. In addition, protein raw materials such as β-lactoglobulin, milk osteopontin and silk fibroin are in the stage of delayed correction, which are required to improve the application materials in a timely manner according to the correction suggestions to meet the normative requirements for the application of novel food ingredients as soon as possible.

In the application project of new varieties of food additives, the overall number of declarations this month remained the same as that of last month, and there were a total of 8 applications for human milk oligosaccharides (HMOs), among which 5 cases were postponed, 3 cases were solicited opinions. The number of its applications accounted for 27% of the total number of the applications of new varieties of food additives, remaining generally stable compared with that of last month, indicating that HMOs still stands out in the application research of food additives. Since 2021, a total of 66 cases of HMOs have been applied. Among them, public opinions have been solicited on 2'FL, 3FL, 3'-SL, 6'-SL, LNnT and LNT; At present, 19 cases have been approved, including 16 cases of 2'FL and 3 cases of LNnT, all of which are derived from genetically modified microorganisms. Antion has successfully completed the application work for two of these cases and has rich successful experience in the application of such projects. Among the remaining HMOs projects, there are 1 case in the acceptance stage, 37 cases with postponed review, 2 cases with review opinions issued, and 7 cases without administrative permission.

Based on rich and successful experience in the application for "three new" foods, Antion suggests that for the "three new" foods that have already been approved, when other enterprises apply for the same product, their quality specifications should be consistent with the approval announcement; For the "three new" foods that are currently under public opinions, if other enterprises apply for the same product, it is recommended to wait until the approval announcement is released before submitting the application materials, so as to shorten the application cycle and reduce the application cost.

Source: Antion

Note: This article is compiled by Antion. Please indicate the source for reprint.